Urinary 11-dehydro thromboxane B2 levels in type 2 diabetic patients before and during aspirin intake
Authors:
- Luci Maria Sant'ANa DusseLDLuci Maria Sant'ANa Dusse
- Ana Paula FernandesAFAna Paula Fernandes
- Karina Braga GomesKGKarina Braga Gomes
- Mirelle Oliveira SóterMSMirelle Oliveira Sóter
- Michelle Teodoro AlvesMAMichelle Teodoro Alves
- Kathryna Fontana RodriguesKRKathryna Fontana Rodrigues
- Fernanda Rocha FreitasFFFernanda Rocha Freitas
- Flavia KomatsuzakiFKFlavia Komatsuzaki
- Marinez Oliveira SousaMSMarinez Oliveira Sousa
- Adriana Aparecida BoscoABAdriana Aparecida Bosco
- Gérson Antônio PianettGPGérson Antônio Pianett
- 1 July 2011
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (15-16) , 1366-1370
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 28 references indexed in Scilit:
- Aspirin for Primary Prevention of Cardiovascular Events in People With DiabetesDiabetes Care, 2010
- Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention SettingDiabetes Care, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary SyndromeDiabetes Care, 2008
- Primary Prevention of Cardiovascular Diseases in People With Diabetes MellitusDiabetes Care, 2007
- Polymorphisms of COX-1 and GP VI associate with the antiplatelet effect of aspirin in coronary artery disease patientsThrombosis and Haemostasis, 2006
- Cyclooxygenase-1 haplotype modulates platelet response to aspirinJournal of Thrombosis and Haemostasis, 2005
- The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosisAmerican Heart Journal, 2005
- Variability in response to aspirin: do we understand the clinical relevance?Journal of Thrombosis and Haemostasis, 2005
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002